These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11041285)

  • 1. Co-administration of furosemide augments tacrolimus-induced impairment in kidney function in rats.
    Nakahama H; Obata K; Sugita M; Oka K; Moriyama T
    Ren Fail; 2000; 22(5):525-34. PubMed ID: 11041285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyclosporine A attenuates the natriuretic action of loop diuretics by inhibition of renal COX-2 expression.
    Höcherl K; Kees F; Krämer BK; Kurtz A
    Kidney Int; 2004 Jun; 65(6):2071-80. PubMed ID: 15149320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Nephrotoxicity of piperacillin combined with furosemide in rats].
    Hori R; Shimakura M; Aramata Y; Kizawa K; Nozawa I; Takahata M; Minami S
    Jpn J Antibiot; 2000 Aug; 53(8):582-91. PubMed ID: 11070820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of add-on tolvaptan in patients with furosemide-resistant congestive heart failure complicated by advanced chronic kidney disease: a sub-analysis of a pharmacokinetics/ pharmacodynamics study.
    Tominaga N; Kida K; Matsumoto N; Akashi YJ; Miyake F; Kimura K; Shibagaki Y
    Clin Nephrol; 2015 Jul; 84(1):29-38. PubMed ID: 25997504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous infusion of furosemide combined with low-dose dopamine compared to intermittent boluses in acutely decompensated heart failure is less nephrotoxic and carries a lower readmission at thirty days.
    Aziz EF; Alviar CL; Herzog E; Cordova JP; Bastawrose JH; Pamidimukala CK; Tojino A; Park TS; Musat D; Kukin M
    Hellenic J Cardiol; 2011; 52(3):227-35. PubMed ID: 21642071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urocortin 2 inhibits furosemide-induced activation of renin and enhances renal function and diuretic responsiveness in experimental heart failure.
    Rademaker MT; Charles CJ; Nicholls MG; Richards AM
    Circ Heart Fail; 2009 Nov; 2(6):532-40. PubMed ID: 19919977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.
    Vasavada N; Saha C; Agarwal R
    Kidney Int; 2003 Aug; 64(2):632-40. PubMed ID: 12846760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prevention of diltiazem in tacrolimus-induced nephrotoxicity: experiment with rats].
    Chen YH; Liang YX; Chen LQ; Liang JJ; Zhang J; Qiu J; Li WL; Hu JB; Xie KJ; Zhong WD; Chen LZ; Zheng KL
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(32):2235-7. PubMed ID: 18001539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
    Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
    Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of FK506 nephrotoxicity by sodium depletion in an experimental rat model.
    Andoh TF; Burdmann EA; Lindsley J; Houghton DC; Bennett WM
    Transplantation; 1994 Feb; 57(4):483-9. PubMed ID: 7509514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement by potent diuretics of renal tubular necrosis induced by cephaloridine.
    Dodds MG; Foord RD
    Br J Pharmacol; 1970 Oct; 40(2):227-36. PubMed ID: 5492895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and structural characteristics of experimental FK 506 nephrotoxicity.
    Andoh TF; Burdmann EA; Lindsley J; Houghton DC; Bennett WM
    Clin Exp Pharmacol Physiol; 1995 Sep; 22(9):646-54. PubMed ID: 8542679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary composition predicts diuretic efficiency of hypertonic saline solution with furosemide therapy and heart failure prognosis.
    Ando T; Okuhara Y; Orihara Y; Nishimura K; Yamamoto K; Masuyama T; Hirotani S
    Heart Vessels; 2018 Sep; 33(9):1029-1036. PubMed ID: 29556693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy and tolerance of different oral doses of torasemide and furosemide in patients with advanced chronic renal failure.
    Kult J; Häcker W; Glocke M
    Arzneimittelforschung; 1988 Jan; 38(1A):212-4. PubMed ID: 3285837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin II AT1 receptor antagonism prevents detrimental renal actions of acute diuretic therapy in human heart failure.
    Chen HH; Redfield MM; Nordstrom LJ; Cataliotti A; Burnett JC
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1115-9. PubMed ID: 12676739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of V2-receptor antagonist tolvaptan and the loop diuretic furosemide in rats with heart failure.
    Veeraveedu PT; Watanabe K; Ma M; Palaniyandi SS; Yamaguchi K; Kodama M; Aizawa Y
    Biochem Pharmacol; 2008 Mar; 75(6):1322-30. PubMed ID: 18179782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of furosemide on low-dose mercuric chloride acute renal failure in the rat.
    Ufferman RC; Jaenike JR; Freeman RB; Pabico RC
    Kidney Int; 1975 Dec; 8(6):362-7. PubMed ID: 1206852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney function and morphology after short-term combination therapy with cyclosporine A, tacrolimus and sirolimus in the rat.
    Nielsen FT; Ottosen P; Starklint H; Dieperink H
    Nephrol Dial Transplant; 2003 Mar; 18(3):491-6. PubMed ID: 12584269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diuretic-induced renal impairment without volume depletion in cirrhosis: changes in the renin-angiotensin system and the effect of beta-adrenergic blockade.
    Wilkinson SP; Wheeler PG; Bernardi M; Smith IK; Williams R
    Postgrad Med J; 1979 Dec; 55(654):862-7. PubMed ID: 44911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.